“Venu Holding Corporation Crushes Sales Records with $10.4 Million in January Fire Pit Suite Sales! �����”

Welcome to the VENU Blog! Record-Breaking Luxury Fire Pit Suite Sales at Venu Holding Corporation Hey there, music lovers and hospitality enthusiasts! Have you heard the exciting news coming out of Venu Holding Corporation? In case you missed it, VENU, a powerhouse in the live music venue and premium hospitality industry, recently announced that they…

Read More

SmartKem Announces Successful $7.65 Million Offering: A Milestone for the Future of Technology

Exciting News from Smartkem Revolutionizing Electronics with Organic Thin-Film Transistors MANCHESTER, England, Dec. 18, 2024 /PRNewswire/ — Smartkem (Nasdaq: SMTK) has just made a groundbreaking announcement that is set to shake up the world of electronics. The company, known for its innovative organic thin-film transistors (OTFTs), has successfully priced concurrent public and private offerings of…

Read More

“Important Shareholder Alert: Pomerantz Law Firm Reminds Investors with Losses to Take Action”

Pomerantz LLP Announces Class Action Lawsuit Against Five9, Inc. NEW YORK, NY / ACCESS Newswire / January 24, 2025 / Pomerantz LLP, a leading law firm specializing in securities class action lawsuits, has announced that a class action lawsuit has been filed against Five9, Inc. (“Five9” or the “Company”) (NASDAQ:FIVN). Investors who have suffered losses…

Read More

Maximize Your Gains: Don’t Miss Out on Eli Lilly’s Q4 Results and Future Growth Potential

Eli Lilly’s Momentum and Future Prospects Introduction Eli Lilly, a renowned pharmaceutical company, has been experiencing a significant boost in its momentum due to the success of its blockbuster GLP-1 therapies, Mounjaro and Zepbound. These therapies have not only fueled revenue growth but also paved the way for long-term margin expansion. Additionally, Eli Lilly’s ethos…

Read More

Unlocking the Power of Sorrento: Webcast Reveals Groundbreaking Clinical Data for Improved Rheumatoid Arthritis Treatment

Sorrento to Host Webcast on Empowering the Lymphatics Overview ATLANTA and SAN DIEGO, Nov. 13, 2022 (GLOBE NEWSWIRE) — Sofusa®, a wholly-owned division of Sorrento Therapeutics (Nasdaq: SRNE, “Sorrento”), today announced that it will host a virtual Key Opinion Leader (KOL) panel discussion titled “Empowering the Lymphatics: Unleashing the Potential of Biologics that Target the…

Read More